Prevalence and Progression of Cognitive Impairment in Atrial Fibrillation Patients after Treatment with Catheter Ablation or Drug Therapy
Table 3
Results of the AF and AF/HF group according to AF therapy in twice performed Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment tool (MoCA) with an intertest interval of 6 months.
Test
Study group
Therapy
n
Mean score
Std. deviation
1. MMSE
AF group
Drug therapy
9
28.00
1.5
0.1
AF/HF group
8
25.4
4.2
2. MMSE
AF group
Drug therapy
9
27.8
1.7
0.3
AF/HF group
8
26.3
3.8
1. MoCA
AF group
Drug therapy
9
22.4
2.8
0.7
AF/HF group
8
21.8
4.8
2. MoCA
AF group
Drug therapy
9
23.7
4.3
0.2
AF/HF group
8
19.4
9.0
1. MMSE
AF group
Ablation
12
26.2
2.9
0.8
AF/HF group
16
26.4
2.4
2. MMSE
AF group
Ablation
12
26.8
2.1
0.5
AF/HF group
16
26.1
3.1
1. MoCA
AF group
Ablation
12
22.4
4.4
0.9
AF/HF group
16
22.2
4.5
2. MoCA
AF-group
Ablation
12
22.9
2.5
0.9
AF/HF group
16
22.8
4.5
AF = atrial fibrillation, HF = heart failure, and SD = standard deviation.
